REVENUE (Tables)

9 Months Ended

Jul. 31, 2026

Revenue from Contract with Customer [Abstract]

The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:



	Three Months Ended July 31,
	2026								2025
	Life Sciences and Diagnostics Markets		Agilent CrossLab		Applied Markets		Total		Life Sciences and Diagnostics Markets		Agilent CrossLab		Applied Markets		Total
	(in millions)
Revenue by Region
Americas	$	369	$	289	$	103	$	761	$	316	$	274	$	93	$	683
Europe	201		221		82		504		201		212		79		492
Asia Pacific	176		276		161		613		153		258		152		563
Total	$	746	$	786	$	346	$	1,878	$	670	$	744	$	324	$	1,738



	Nine Months Ended July 31,
	2026								2025
	Life Sciences and Diagnostics Markets		Agilent CrossLab		Applied Markets		Total		Life Sciences and Diagnostics Markets		Agilent CrossLab		Applied Markets		Total
	(in millions)
Revenue by Region
Americas	$	1,039	$	851	$	313	$	2,203	$	953	$	805	$	272	$	2,030
Europe	618		658		264		1,540		568		594		235		1,397
Asia Pacific	500		794		474		1,768		450		754		456		1,660
Total	$	2,157	$	2,303	$	1,051	$	5,511	$	1,971	$	2,153	$	963	$	5,087

The following table presents the company’s total revenue disaggregated by end markets and by revenue type:


	Three Months Ended				Nine Months Ended
	July 31,				July 31,
	2026		2025		2026		2025
	(in millions)
Revenue by End Markets
Pharmaceutical and Biotechnology	$	707	$	629	$	2,010	$	1,817
Chemicals and Advanced Materials	430		399		1,264		1,147
Diagnostics and Clinical	284		258		842		753
Food	158		157		471		472
Academia and Government	128		132		390		404
Environmental and Forensics	171		163		534		494
Total	$	1,878	$	1,738	$	5,511	$	5,087

Revenue by Type
Instrumentation	$	643	$	599	$	1,919	$	1,774
Non-instrumentation and other	1,235		1,139		3,592		3,313
Total	$	1,878	$	1,738	$	5,511	$	5,087

Contract Liabilities and Changes in Balances

The following table provides information about contract liabilities (deferred revenue) and the changes in the balances during the nine months ended July 31, 2026:


	Contract Liabilities
	(in millions)

Ending balance as of October 31, 2025	$	803
Net revenue deferred in the period	498
Revenue recognized that was included in the contract liability balance at the beginning of the period	(487)
Change in deferrals from customer cash advances, net of revenue recognized	7

Currency translation and other adjustments	1
Ending balance as of July 31, 2026	$	822